Related by context. Frequent words. (Click for all words.) 61 debt extinguishments 59 Chiral Quest 59 ESP Pharma 59 BioCheck 59 Ibis Biosciences Inc. 59 Innovive 58 StromaCel Inc. 57 Bio Quant 57 Revance 57 Sunesis Pharmaceuticals 56 Prestwick Pharmaceuticals 56 b Excludes 56 OncoGenex Technologies 55 Dynogen 55 Emisphere Technologies 55 Ore Pharmaceuticals 55 InfrastruX 55 Enzo Biochem 55 Merger Transaction 55 depreciation depletion amortization 54 Furiex 54 Zymogenetics 54 c Represents 54 HLTH Corporation 54 Xantic 54 TargeGen 54 Cortelco 54 MYBA recently 54 ACADIA Pharmaceuticals 54 EntreMed Inc. 54 Petrosearch Energy 54 IOMED 54 Flow Through Financing 54 Ilypsa 54 Esprit Pharma 54 Tikcro 54 Portola Pharmaceuticals 53 Altus Pharmaceuticals 53 Coley Pharmaceutical Group 53 Inergy Holdings 53 Inpharmatica 53 Nellix 53 NGAS Resources 53 NovaCardia 53 Ardea Biosciences 53 ZIOPHARM Oncology 53 Avidia 53 Tepnel 53 Stressgen 53 Adnexus 53 AutoImmune 53 ofapproximately 53 FoldRx 53 Xcyte 53 CoGenesys 53 Sirona Biochem 53 ACM Managed Dollar 53 QEP Resources 53 Vicuron Pharmaceuticals 53 Proteolix 53 Xenogen 52 Syntonix 52 Harland Acquisition 52 Neurobiological Technologies Inc. 52 TranSwitch indebtedness 52 Filtran 52 Idera Pharmaceuticals 52 Fairborne Energy Ltd. 52 Pharmion Corporation 52 Enzon Pharmaceuticals 52 CuraGen Corporation 52 c Includes 52 Cougar Biotechnology Inc. 52 Adnexus Therapeutics 52 ACLARA 52 TorreyPines Therapeutics 52 Sturm Foods 52 NPREIT 52 Katonah Debt Advisors 52 TFN NEWS BRIEFING Mergers 52 Proximagen 52 PacWest Bancorp 52 Botaneco 52 NGEx 52 Oncolin 52 Facet Biotech 52 Hybridon 52 Cardiokine 52 ALZA Corporation 52 Private Placement Offering 52 Intangibles amortization 52 LFB Biotechnologies 52 Movetis 52 Guidant vascular 52 Substantial Issuer Bid 52 Excluding goodwill impairment 52 Taligen 52 Alange 52 Transcept Pharmaceuticals 51 Interpharm 51 Cephalon NASDAQ CEPH